PRF Technologies Ltd. (PRFX)
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Last price
- $0.87
- As of
Kresmion compiles this page from PRFX's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
PRF Technologies Ltd. (PRFX): 1 institutional manager tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 6-K filed 2026-11-05.
See the full PRFX dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for PRFX on one page. Preview it with sample data, then open it live with a free account.
Preview the PRFX dossierActive events for PRFX
- medium13F: new position
CITADEL ADVISORS LLC new position in PRFX
- mediumEarnings above estimates
Q3-2023: Beat consensus by 133.6% - EPS $57.6 vs $-171.36 estimate
- mediumEarnings below estimates
Q4-2023: Missed consensus by 104.6% - EPS $-373.2 vs $-182.376 estimate
- mediumEarnings below estimates
Q1-2024: Missed consensus by 11.1% - EPS $-326.4 vs $-293.76 estimate
- mediumEarnings below estimates
Q2-2024: Missed consensus by 67.8% - EPS $-213.6 vs $-127.296 estimate
FREE, NO ACCOUNT
Every event on PRFX, as it fires
You are seeing 5 of 9 events recorded on PRFX since 2026-05-17.
The five above landed across 2 days. The other 4 were recorded on 1 other days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
PRFX positions held by the managers we follow (2026Q2)
What the managers we follow bought and sold in Q2 2026
| Manager / security | Market value | % of reported value |
|---|---|---|
| CITADEL ADVISORS LLC FundCUSIP M77798201 · 2026Q2 | $39K | 0.00% |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. The share of reported value is each position's value over the sum of the values that manager reported for the quarter; option lines are not in that sum, as on each fund page. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, PRFX
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
- 6-KSEC EDGAR ↗
Going concern statement
PRFX's 20-F filed Mar 26, 2026 states:
…indicating that there is a substantial doubt about our ability to continue as a going concern.
Read the 20-F on SEC EDGAR Every company with a going concern statement
More data on PRFX
PRFX against its peers
PRFX's operating margin of -30129.4% ranks in the 14th percentile of 10 Drug Manufacturers - Specialty & Generic sub-industry peers, fiscal periods ending between 2025-05-31 and 2026-06-30.
| Metric | PRFX | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 17000 USD | 13.8M USD | 25 | 9 |
| Gross margin | n/a | 35.3% | n/a | 11 |
| Operating margin | -30129.4% | -19.2% | 14 | 10 |
| Net margin | -29541.2% | -20.6% | 13 | 11 |
| Return on equity | -58.8% | -42.0% | 45 | 9 |
Peers (14): APUS, CVSI, SBFM, GELS, SNOA, CBIH, YCBD, BUDZ, CPMD, UPC, LVRLF, INM, IMCC, CABR. Left out: CTTH (period gap), RDHL (period gap), PLSH (period gap), CANN (period gap), PCYN (period gap), CBDL (no annual filing), NASC (period gap), TRUFF (no annual filing), SFWJ (no annual filing), CNTMF (no annual filing), KAYS (period gap). Fiscal periods ending between 2025-05-31 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (PRFX: 20-F), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in PRFX on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on PRFX in the last 180 days.
Upstream: SEC EDGAR filings for PRFX
Kresmion, "PRF Technologies Ltd. (PRFX) institutional holdings and SEC filings", data as of 2026-11-05, https://kresmion.com/research/PRFX. Upstream data: SEC EDGAR filings for PRFX.
Link to this data (HTML):
<a href="https://kresmion.com/research/PRFX">PRF Technologies Ltd. (PRFX) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow PRFX on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to PRFX for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.